Media Database
>
Hugo Mathers

Hugo Mathers

Reporter at Capital Brief

Contact this person
Email address
h*****@*******.comGet email address
Influence score
28
Location
Australia
Languages
  • English
Covering topics
  • Business
  • Finance & Banking Services
  • Politics

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

capitalbrief.com

Clarity Pharma shares edge up on clinical trial result, UoQ supply deal

Shares in Clarity Pharmaceuticals edged up in early trading, having briefly jumped more than 7%, after the clinical-stage radiopharmaceutical company reported positive clinical trial results for its prostate cancer treatment Cu-SAR-bisPSMA, and signed a new supply agreement with The University of Queensland.
capitalbrief.com

Clarity Pharmaceuticals shares slide 10% on further losses

Clarity Pharmaceuticals shares dropped by more than 10% in morning trade after the clinical-stage radiopharmaceutical company extended its losses from $17.2 million to $23.5 million during the first half.
capitalbrief.com

Energy sector leads ASX gains as China data spurs oil prices

Oil and gas companies advanced as oil prices started the week higher, after upbeat manufacturing data from China boosted investor sentiment and offset uncertainty posed by impending US tariffs on China, Mexico and Canada.
capitalbrief.com

Star Entertainment pauses trading, casting earnings in doubt

Star Entertainment paused trading minutes before market opened this morning, with the embattled casino operator due to publish its half-year financial results today.
capitalbrief.com

Bendigo Bank reduces home loan interest rates after RBA cut

Bendigo Bank has announced a reduction to the pricing of home loan products following the Reserve Bank's decision to cut the cash rate by 0.25% per year on Tuesday.
capitalbrief.com

NAB leads banking selloff as financial stocks shed 2%

NAB led further declines across Australia's big four lenders on Thursday following the bank's disappointing first-quarter result on Wednesday.
capitalbrief.com

Clarity Pharmaceuticals receives third FDA review for prostate canc...

Sydney-based Clarity Pharmaceuticals has received a third fast track designation (FTD) from the US Food and Drug Administration (FDA) for its imaging agent Cu-SAR-bisPSMA, a novel diagnostic option for patients with prostate cancer.
capitalbrief.com

BHP climbs 2% as mining stocks surge

Mining stocks were among the biggest winners on the ASX after new data pointed to a stabilising property market in China and gold resumed its weeks-long rally.
capitalbrief.com

Sigma Healthcare completes Chemist Warehouse acquisition

Chemist Warehouse is now a wholly owned subsidiary of Sigma Healthcare, after the listed pharmacy wholesaler completed its buyout of the retail chain.
capitalbrief.com

How a seasoned ASX exec came to lead lithium tech startup ElectraLith

Charlie McGill used to work in senior management at Austal, Wesfarmers and Incitec Pivot. Now he’s tinkering in a lab at Monash University.
capitalbrief.com

Sigma Healthcare upgrades guidance on Chemist Warehouse contract

Pharmacy wholesaler Sigma Healthcare has upgraded its full-year normalised EBIT guidance for the year ending 31 January 2025, following "improved operational performance" boosted by a new Chemist Warehouse supply contract.